Pain, Allodynia, and Serum Serotonin Level in Orofacial Pain of Muscular Origin

Journal of Orofacial Pain

Volumn 13, Issue 1, 1999, Pages 56-62

  Ernberg, Malin ^a,b   Hedenberg Magnusson, Britt ^a   Alstergren, Per ^a   Lundeberg, Thomas ^a   Kopp, Sigvard ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b School of Dentistry   (Sweden)

Author keywords

Allodynia; Fibromyalgia; Local myalgia; Serotonin; Temporomandibular disorders

Indexed keywords

SCAVENGER; SEROTONIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; CASE CONTROL STUDY; CHEMISTRY; COMPARATIVE STUDY; FACE MUSCLE; FACE PAIN; FEMALE; FIBROMYALGIA; HUMAN; MALE; MASTICATORY MUSCLE; MIDDLE AGED; MYOFASCIAL PAIN; NONPARAMETRIC TEST; PAIN ASSESSMENT;

ADULT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; FACIAL MUSCLES; FACIAL PAIN; FEMALE; FIBROMYALGIA; FREE RADICAL SCAVENGERS; HUMANS; MALE; MASTICATORY MUSCLES; MIDDLE AGED; PAIN MEASUREMENT; SEROTONIN; STATISTICS, NONPARAMETRIC; TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME;

EID: 0033452377     PISSN: 10646655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Han SC, Harrison P. Myofascial pain syndrome and trigger-point management. Reg Anesth 1997;22:89-101.
2. The American Academy of Orofacial Pain. Differential diagnosis and management considerations of temporomandibular disorders. In: Okeson JP (ed). Orofacial Pain. Guidelines for Assessment, Diagnosis and Management. Chicago: Quintessence, 1996:137-141.
3. Foreman PA. Temporomandibular joint and myofascial pain dysfunction - Some current concepts. Part 1: Diagnosis. NZ Dent J 1985;81:47-52.
4. Larsson SE, Bodegard L, Henriksson KG, Oberg PA. Chronic trapezius myalgia. Morphology and blood flow studied in 17 patients. Acta Orthop Scand 1990;61:394-398.
5. Harness DM, Donlon WC, Eversole LR. Comparison of clinical characteristics in myogenic, TMJ internal derangement and atypical facial pain patients. Clin J Pain 1990;6:4-17.
6. Scudds RA, McCain GA, Rollman GB, Harth M. Improvements in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline. J Rheumatol 1989;19(suppl):98-103.
7. Wolfe F, Russell IJ, Vipraio G, Ross K, Anderson J. Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J Rheumatol 1997;24:555-559.
8. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee, Arthritis Rheum 1990;33:160-172.
9. Moldofsky H, Warsh JJ. Plasma tryptophan and musculoskeletal pain in non-articular rheumatism ("fibrositis syndrome"). Pain 1978;5:65-71.
10. Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC. Plasma tryptophan and other amino acids in primary fibromyalgia: A controlled study. J Rheumatol 1992;19:90-94.
11. Russell IJ, Vaeroy H, Javors M, Nyberg F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992;35:550-556.
12. Stratz T, Samborski W, Hrycaj P, Pap T, Mackiewicz S, Mennet P, Muller W. Die serotoninkonzentration im serum bei patienten mit generalisierter tendomyopathie (fibromyalgie) und chronischer polyarthritis. Med Klin 1993;88:458-462.
13. Carette S, McCain GA, Bell DA, Fam AC. Evaluation of amitriptyline in primary fibrositis. A double-blind, placebocontrolled study. Arthritis Rheum 1986;29:655-659.
14. Marcus DA. Serotonin and its role in headache pathogenesis and treatment. Clin J Pain 1993;9:159-167.
15. Alstergren P, Ernberg M, Kopp S, Lundeberg T, Theodorsson E. TMJ pain in relation to circulating neuropeptide Y, serotonin, and interleukin-1β in rheumatoid arthritis. J Orofac Pain 1999;13:49-55.
16. Sharav Y, Singer E, Schmidt E, Dionne RA, Dubner R. The analgesic effect of amitriptyline on chronic facial pain. Pain 1987;31:199-209.
17. Krough-Poulsen W. Management of the occlusion of teeth: Examination, diagnosis, treatment. In: Schwartz NL, Chayes CM (eds). Facial Pain and Mandibular Dysfunction. Philadelphia: WB Saunders, 1972:252-258.
18. Russell IJ, Vipraio GA, Morgan WW, Bowden CL. Is there a metabolic basis for the fibrositis syndrome? Am J Med 1986;81:50-54.
19. Candito M, Souetre E, Iordache A, Pringuey D, Ardisson JL, Chambon P, Darcourt G. Diurnal variation in total plasma tryptophan in controls and in depression. J Psychiatr Res 1990;24:227-230.
20. Mense S. Nociception from skeletal muscle in relation to clinical muscle pain. Pain 1993;54:241-289.
21. Kosek E, Ekholm J, Hansson P. Sensory dysfunction in fibromyalgia patients with implications for pathogenic mechanisms. Pain 1996;68:375-383.
22. Hedenberg-Magnusson B, Ernberg M, Kopp S. Symptoms and signs of temporomandibular disorders in patients with fibromyalgia and local myalgia of the temporomandibular system. A comparative study. Acta Odontol Scand 1997;55:344-349.